EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comorbid Alzheimer's Disease and Type 2 Diabetes Microbiota Shape Age‐Associated Gut–Brain Axis Profiles

Alessandro Atzeni iD, Jonas Mingaila, Gediminas Alzbutas, Rokas Lukoševičius, Justinas Drūteika, Kamila Łuczyńska, Rima Ramonaitė, Tadeusz Pietras, Kasper Sipowicz, Dovilė Kiudelytė, Karolina Keršytė, Emilija Keževičiūtė und 5 weitere

Aging Cell · 2026

DOI: 10.1111/acel.70488 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging Cell, 2026. Verfasst von Alessandro Atzeni und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Models, Institute of Biochemistry, Life Sciences Center, Vilnius University, Vilnius, Lithuania. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Alzheimer Disease, Gastrointestinal Microbiome, Aging. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Council of Lithuania, Lietuvos Mokslo Taryba.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) and type 2 diabetes mellitus (T2DM) share metabolic and inflammatory mechanisms, potentially mediated by the gut microbiota, yet the neurobiological impact of comorbid AD+T2DM microbiota from elderly donors remains unexplored. Fecal microbiota from healthy, AD, T2DM, and AD+T2DM postmenopausal female donors (aged 56–89 years) was transplanted into antibiotic‐treated male mice. Behavioral testing, blood profiling, hippocampal neurotrophic gene expression, and 16S rRNA sequencing with taxonomic, functional, and metabolic analyses were performed. Human AD+T2DM microbiota displayed the greatest dysbiosis, characterized by enrichment of pro‐inflammatory taxa, depletion of butyrate‐producing genera, and loss of neuroprotective metabolic pathways. FMT induced robust engraftment, with AD+T2DM recipients diverging most from controls (PERMANOVA R 2 = 0.209, p = 0.001) and healthy recipients (PERMANOVA R 2 = 0.111, p = 0.002). Donor age contributed significantly to recipient microbiota variation ( R 2 = 0.028, p = 0.006), suggesting transmission of aging‐associated microbial signatures. Hippocampal neurotrophic gene expression was most suppressed in AD+T2DM recipients (adjusted p value < 0.05) and negatively correlated with disease‐ and aging‐associated taxa and microbial functions (|r| > 0.4, FDR p < 0.05). AD recipients showed reduced olfactory discrimination and increased daytime locomotor activity. Metabolic network analysis revealed depletion of flavonoid, isoflavonoid, and lignan biosynthesis pathways in disease recipients. These findings suggest that microbiota from elderly donors with comorbid AD+T2DM may induce gut–brain axis alterations, linking aging, metabolic dysfunction, and neurodegeneration through convergent taxonomic, functional, and neurotrophic changes. We underscore the potential role of age‐associated gut microbial signatures in modulating neurobiological outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Alzheimer DiseaseGastrointestinal MicrobiomeAgingBrainHumansAnimalsFemaleAgedMiddle AgedMiceAged, 80 and overMaleComorbidity

Stichwörter der Autor:innen

Alzheimer's diseaseagingcomorbidityfecal microbiota transplantationgut microbiotagut–brain axistype 2 diabetes mellitus

Autor:innen und Institutionen

  • Department of Biological Models, Institute of Biochemistry, Life Sciences Center, Vilnius University, Vilnius, Lithuania.
  • Institute for Digestive Research, Lithuanian University of Health Sciences, Kaunas, Lithuania.
  • Department of Neurology, Lithuanian University of Health Sciences, Hospital of Lithuanian University of Health Sciences Kauno Klinikos, Kaunas, Lithuania.
  • Institute of Genetics and Animal Biotechnology of the Polish Academy of Sciences, Magdalenka, Poland.
  • The Second Department of Psychiatry, Institute of Psychiatry and Neurology in Warsaw, Warsaw, Poland.
  • Department of Clinical Pharmacology, Medical University of Lodz, Lodz, Poland.

ORCID-Profile: Alessandro Atzeni, Juozas Kupčinskas, Jordi Mayneris-Perxachs, Daiva Baltriukienė, Aurelijus Burokas

Förderung

  • Research Council of Lithuania
  • Lietuvos Mokslo Taryba

Zitieren

APA

Atzeni, A., Mingaila, J., Alzbutas, G., Lukoševičius, R., Drūteika, J., Łuczyńska, K., Ramonaitė, R., Pietras, T., Sipowicz, K., Kiudelytė, D., Keršytė, K., Keževičiūtė, E., Najūtė, G., Kupčinskas, J., Mayneris-Perxachs, J., Baltriukienė, D., & Burokas, A. (2026). Comorbid Alzheimer's Disease and Type 2 Diabetes Microbiota Shape Age‐Associated Gut–Brain Axis Profiles. Aging Cell. https://doi.org/10.1111/acel.70488

Vancouver

Atzeni A, Mingaila J, Alzbutas G, Lukoševičius R, Drūteika J, Łuczyńska K, et al. Comorbid Alzheimer's Disease and Type 2 Diabetes Microbiota Shape Age‐Associated Gut–Brain Axis Profiles. Aging Cell. 2026. doi:10.1111/acel.70488

BibTeX
@article{Atzeni2026,
  author = {Atzeni, Alessandro and Mingaila, Jonas and Alzbutas, Gediminas and Lukoševičius, Rokas and Drūteika, Justinas and Łuczyńska, Kamila and Ramonaitė, Rima and Pietras, Tadeusz and Sipowicz, Kasper and Kiudelytė, Dovilė and Keršytė, Karolina and Keževičiūtė, Emilija and Najūtė, Greta and Kupčinskas, Juozas and Mayneris-Perxachs, Jordi and Baltriukienė, Daiva and Burokas, Aurelijus},
  title = {Comorbid Alzheimer's Disease and Type 2 Diabetes Microbiota Shape Age‐Associated Gut–Brain Axis Profiles},
  journal = {Aging Cell},
  year = {2026},
  doi = {10.1111/acel.70488}
}
Kostenlos starten →